Загрузка...
Management of atrial fibrillation in patients taking targeted cancer therapies
Atrial fibrillation (AF) is frequently observed in patients being treated for cancer and can lead to increased morbidity and mortality in this population. With the use of newer, targeted cancer therapies, several drug-drug interactions have emerged that complicate the use of antiarrhythmic drugs (AA...
Сохранить в:
| Опубликовано в: : | Cardiooncology |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7048041/ https://ncbi.nlm.nih.gov/pubmed/32153998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40959-017-0021-y |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|